The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
9873586 |
50 |
PD 176252--the first high affinity non-peptide gastrin-releasing peptide (BB2) receptor antagonist. |
Cambridge University Forvie Site |
| 66 |
Design and synthesis of a targeted set of aromatic amino acid derivatives for identification of new lead compounds |
TBA |
| 42 |
PD 165929 the first high affinity non-peptide neuromedin-B (NMB) receptor selective antagonist |
TBA |
24900253 |
28 |
Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity |
TBA |
20219372 |
114 |
Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity. |
Merck Research Laboratories |
20167483 |
90 |
Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonists. |
Merck Research Laboratories |
19553112 |
39 |
Discovery and optimization of a novel Neuromedin B receptor antagonist. |
Amgen |
18818070 |
28 |
Discovery of small molecule agonists for the bombesin receptor subtype 3 (BRS-3) based on an omeprazole lead. |
Glaxosmithkline |
15634004 |
20 |
Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study. |
National Center For Scientific Research Demokritos |
15149640 |
34 |
Identification and optimization of novel partial agonists of neuromedin B receptor using parallel synthesis. |
Tularik |
12723954 |
47 |
Design of selective peptidomimetic agonists for the human orphan receptor BRS-3. |
Technische UniversitäT MüNchen |
26833890 |
18 |
Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2H,8H-pyrano[2,3-f]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease. |
Yogi Vemana University |
26914186 |
3 |
Arylazolyl(azinyl)thioacetanilides: Part 19: Discovery of Novel Substituted Imidazo[4,5-b]pyridin-2-ylthioacetanilides as Potent HIV NNRTIs Via a Structure-based Bioisosterism Approach. |
Shandong University |